Format

Send to:

Choose Destination
See comment in PubMed Commons below
South Med J. 1996 Nov;89(11):1101-3.

Long-term subcutaneous infusion of midazolam for refractory delirium in terminal breast cancer.

Author information

  • 1Department of Internal Medicine, Alvin C. York Veterans Affairs Medical Center, Murfreesboro, Tenn, USA.

Abstract

We describe the case of a 56-year-old woman with terminal metastatic breast cancer who had delirium in the form of frightening hallucinations, paranoid delusions, and nightmares resulting in violent agitation. During this period, her bone pains from metastases were well controlled with narcotic analgesics, but her delirium proved refractory to standard doses of drugs such as lorazepam, diazepam, and haloperidol. We report the use of a subcutaneous infusion of midazolam at home and its effectiveness in control of her delirium after other drugs had failed.

PMID:
8903298
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk